Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Juno gives up on lead CAR-T drug after deaths

ROCKET trial for leukaemia patients ended

Teva launches online cancer portal My Day

Follows social listening project on gender differences in cancer discussions

Holding on to hope for Alzheimer’s advances

Despite another late-stage failure, now is not the time to give up on the disease

- PMLiVE

Inspired Science expands team

Neil McLelland and Chloe Malloy join the agency

Celgene building

Celgene bags US priority review for cancer metabolism drug

First approval for enasidenib could be just six months away

Takeda pilots Apple Watch depression app

Partners with Cognition Kit on patient monitoring wearable

- PMLiVE

Novo Nordisk’s North American head Jakob Riis to leave

He will be replaced by Doug Langa

- PMLiVE

NICE turns down first-line Keytruda for lung cancer

High cost of drug puts it above cost-effectiveness threshold

- PMLiVE

Stress testing for the perfect compliance storm

...as governments and regulators impose new legislation and strengthen their compliance regimes

Influence mapping to improve the efficiency and effectiveness of your messaging

As companies work to find innovative marketing techniques to cut through the noise, influence mapping has seen an increase in popularity. Associate Consultant Pany Koizi talks through how to get...

Blue Latitude Health

- PMLiVE

Amgen’s Kyprolis tops Velcade in myeloma trial

Hopes ENDEAVOR trial results will give it an edge over Takeda's brand

- PMLiVE

FDA sets August review date for Teva’s movement disorder drug

Could be first approved treatment for tardive dyskinesia

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links